コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nt amounts of protons and to maintain stable blood pH.
2 epithelia, contributing to the buffering of blood pH.
3 t longer than 2 wks and lower precannulation blood pH.
4 roblems related to fluids, electrolytes, and blood pH.
5 well as generating new HCO3- for regulating blood pH.
6 and thereby contributes to the regulation of blood pH.
7 onate administration significantly increased blood pH.
8 calcium-phosphorus product, or to changes in blood pH.
9 ing again being dependent on zinc and normal blood pH.
10 lays an important role in maintaining normal blood pH.
11 e blood glucose levels and prevent a fall in blood pH.
16 acidification) accompanied by an increase in blood pH and a decrease in pCO(2) compared to WT litterm
19 on model to provide continuous monitoring of blood pH and arterial CO(2) in between gaps of blood dra
20 er (KME) supplement have been shown to lower blood pH and arterial CO(2), which are important regulat
21 in vasopressor requirements, improvement in blood pH and in parameters of intracranial pressure (ICP
22 d that optimal binding takes place at normal blood pH and is markedly reduced when pH is adjusted wit
24 the potential implications of fish's unique blood pH and plasma composition on the distribution (D)
26 mately 50%, and delayed recovery of arterial blood pH and standard [HCO(3) (-)] from their initial de
28 atient trajectories as a function of lactate blood pH and volumes, among other relevant physiological
29 h, five-minute Apgar score, umbilical-artery blood pH, and morbidity due to prematurity for all singl
31 l systemic roles in renal acid excretion and blood pH balance, male fertility, bone remodeling, synap
32 10His/p.Gln913Arg) in an individual with low blood pH, blindness and neurological signs that resemble
38 ed between SB use and blood pH (Non-SB use x blood pH > 7.18; OR 1.56; 95% CI 1.01-2.41; p value = 0.
39 95% CI 0.45 to 0.94), and pre-ECMO arterial blood pH >7.17 (OR 0.50, 95% CI 0.30 to 0.84) were assoc
40 -) and H(+) production->decreased muscle and blood pH->with increased H(+) buffered by blood [HCO(3)
41 6 +/- 9 torr (7.9 +/- 1.2 kPa) (p < .01) and blood pH had decreased from 7.317 +/- 0.041 to 7.151 +/-
48 ) had lactic acidosis defined as an arterial blood pH less than 7.35 and a lactate concentration grea
49 new vision deficits, metabolic acidosis with blood pH </= 7.15, persistent metabolic acidosis despite
50 (OR 3.06, 95% CI 1.42 to 6.58), and arterial blood pH <7.2 (OR 2.23, 95% CI 1.23 to 4.06) were associ
51 eaths per minute (OR, 1.6; 95% CI, 1.1-2.3), blood pH <7.35 (OR, 3.2; 95% CI, 1.8-5.7), blood urea ni
52 t interactions were noted between SB use and blood pH (Non-SB use x blood pH > 7.18; OR 1.56; 95% CI
54 nutes, neonatal seizure, an umbilical-artery blood pH of 7.05 or less with a base deficit of 12 mmol
58 rium caused a transient decrease in arterial blood pH (pHa) and a short but intense burst of afferent
59 so elicited pronounced decreases in arterial blood pH, pO(2) and sO(2) accompanied by pronounced incr
60 ter controlling for recipient factors, donor blood pH positively predicted lung graft survival (OR 1.
62 intravenously as a bolus to correct arterial blood pH toward a target arterial pH of 7.40 (dose calcu
63 e risk in term infants with umbilical-artery blood pH values of 7.0 or less (180; 95 percent confiden
64 gar scores of 3 or less and umbilical-artery blood pH values of 7.0 or less was approximately doubled
65 Paired Apgar scores and umbilical-artery blood pH values were determined for 145,627 infants to a
67 n the pH-uncorrected group (n = 6), arterial blood pH was allowed to decreased without treatment.
73 (-) and H(+) production decreased muscle and blood pH with increased H(+) buffered by blood [HCO(3)(-
75 be significantly attenuated by correction of blood pH with the administration of sodium bicarbonate,